| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2011 | US8017558 Carboxamides for controlling micro-organisms in plant and material protection |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017368 Molecular delivery to cells using aspirin-related compounds |
| 09/13/2011 | US8017162 Anti-inflammatory agent |
| 09/13/2011 | US8017160 Concurrent administering magnesium salt and quaternary ammonium compound, phosphatides and, or acid |
| 09/13/2011 | US8017159 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 09/13/2011 | US8017151 Amphiphilic polymer-protein conjugates and methods of use thereof |
| 09/13/2011 | US8017146 Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised |
| 09/13/2011 | US8017144 Controlled release polymeric compositions of bone growth promoting compounds |
| 09/13/2011 | US8017143 Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith |
| 09/13/2011 | US8017140 Drug-delivery stent formulations for restenosis and vulnerable plaque |
| 09/13/2011 | US8017109 Endosomolytic poly(acrylate) polymers |
| 09/13/2011 | US8017107 Perfluorocyclobutane crosslinked hydrogels |
| 09/13/2011 | CA2691149C Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r-and s-citalopram |
| 09/13/2011 | CA2670605C Substituted arylpyrazoles |
| 09/13/2011 | CA2640451C Medicine for transnasal administration |
| 09/13/2011 | CA2639407C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 09/13/2011 | CA2628857C Formulation and method for treating neoplasms by inhalation |
| 09/13/2011 | CA2619077C Methods for the preparation of hcv polymerase inhibitors |
| 09/13/2011 | CA2615921C Hepatitis c inhibitor peptide analogs with a quinoline or a thienopyridine moiety |
| 09/13/2011 | CA2593161C Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries |
| 09/13/2011 | CA2582276C Alkil-pyridines as 11-beta inhibitors for diabetes |
| 09/13/2011 | CA2570717C Cetp inhibitors |
| 09/13/2011 | CA2560402C Tetrahydroquinoline derivatives and a process for preparing the same |
| 09/13/2011 | CA2552503C Pyrrolopyrimidine and pyrrolotriazine derivatives |
| 09/13/2011 | CA2551168C 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 09/13/2011 | CA2548659C Food and feed supplement and its use |
| 09/13/2011 | CA2539489C Methods and kits for enhancing ability to learn in a puppy or kitten |
| 09/13/2011 | CA2528096C Cis-imidazolines as mdm2 inhibitors |
| 09/13/2011 | CA2522318C Drug for preventing or treating angiogenic eye diseases |
| 09/13/2011 | CA2518964C Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 09/13/2011 | CA2515590C Pten inhibitor or maxi-k channels opener |
| 09/13/2011 | CA2514614C Vitamin d3 lactone derivatives |
| 09/13/2011 | CA2509981C Hetero substitued sodium channel blockers |
| 09/13/2011 | CA2508952C Tetrahydroquinoline derivatives and their use as follicle stimulating hormone receptor modulators |
| 09/13/2011 | CA2508335C Imidazole derivatives having affinity for alpha 2 receptors activity |
| 09/13/2011 | CA2503860C Stabilised nadh/nadph compositions |
| 09/13/2011 | CA2500675C Substituted gamma-phenyl-delta-lactams and uses related thereto |
| 09/13/2011 | CA2493614C Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
| 09/13/2011 | CA2492410C Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 09/13/2011 | CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/13/2011 | CA2480276C Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 09/13/2011 | CA2472957C Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis |
| 09/13/2011 | CA2469075C Pyrrolidine derivatives as prostaglandin modulators |
| 09/13/2011 | CA2468982C Dietary modifications to improve fertility |
| 09/13/2011 | CA2467763C Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 09/13/2011 | CA2452606C Tetrahydroquinoline derivatives |
| 09/13/2011 | CA2451979C Novel modifications of the trometamol salt of r-thioctic acid and method for producing the same |
| 09/13/2011 | CA2448251C Metal complexes and therapeutic uses thereof |
| 09/13/2011 | CA2441565C Bisarylamines as potassium channel openers |
| 09/13/2011 | CA2440238C Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/13/2011 | CA2430070C A process for the preparation of taxan derivatives |
| 09/13/2011 | CA2428800C In vivo use of fluid absorbent polymers |
| 09/13/2011 | CA2425268C Pyridinone derivatives for treatment of atherosclerosis |
| 09/13/2011 | CA2407573C Imidazopyridine derivatives |
| 09/13/2011 | CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/13/2011 | CA2388840C Treatment of lymphomas, leukemias, breast carcinomas, astrocytomas, melanomas, leiomyomas, and related tumors |
| 09/13/2011 | CA2378187C Methods for treating therapy-resistant tumors |
| 09/13/2011 | CA2356637C Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
| 09/13/2011 | CA2350519C Chromone enteric release formulation |
| 09/13/2011 | CA2334119C Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 09/13/2011 | CA2313270C Use of deferiprone in treating and preventing iron-induced cardiac disease |
| 09/13/2011 | CA2250792C Cocoa extract compounds and methods for making and using the same |
| 09/13/2011 | CA2224127C Flagellin gene, flac of campylobacter |
| 09/13/2011 | CA2199289C Novel compositions containing phosphoglycero ethers, and use thereof for treating neurodegenerative diseases |
| 09/12/2011 | CA2733694A1 Selegiline-containing adhesive preparation |
| 09/12/2011 | CA2733692A1 Selegiline-containing adhesive preparation |
| 09/12/2011 | CA2733633A1 Selegiline-containing adhesive preparation |
| 09/12/2011 | CA2697887A1 Modulating and/or detecting activation induced deaminase and methods of use thereof |
| 09/10/2011 | CA2695782A1 Prostate perform |
| 09/09/2011 | WO2011109724A1 Compositions and methods for treating and/or preventing cardiovascular disease |
| 09/09/2011 | WO2011109711A1 Glucocorticoid drugs as smoothened agonists |
| 09/09/2011 | WO2011109704A1 Antimicrobial cationic stereoids and methods of use |
| 09/09/2011 | WO2011109697A1 Inactivation of reverse transcriptases by azido-diarylpyrimidines |
| 09/09/2011 | WO2011109650A1 Method of treating acute lung injury using sphingosine 1 phosphate analoges or sphingosine 1 phosphate receptor agonists |
| 09/09/2011 | WO2011109593A1 Substituted-5-aminopyrrolo/pyrazolopyridines |
| 09/09/2011 | WO2011109587A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 09/09/2011 | WO2011109579A1 Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof |
| 09/09/2011 | WO2011109536A1 Treatment of lupus arthritis using laquinimod |
| 09/09/2011 | WO2011109526A1 Treatment of lupus nephritis using laquinimod |
| 09/09/2011 | WO2011109521A1 Polyamine-dihydroxybenzoic acid conjugate hydrogels as iron chelators |
| 09/09/2011 | WO2011109471A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 09/09/2011 | WO2011109470A1 Heteroaryl nitrile compounds useful as inhibitors of cathepsin-s |
| 09/09/2011 | WO2011109469A1 Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
| 09/09/2011 | WO2011109464A1 Deuterated tetrahydronaphthalene derivatives |
| 09/09/2011 | WO2011109403A1 Use of (3r)-4-{[(1s)-2-methyl-1- (2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence |
| 09/09/2011 | WO2011109387A1 Radiotherapy combined with hypoxic cell sensitizers |
| 09/09/2011 | WO2011109380A1 Nucleic acids for targeting multiple regions of the hcv genome |
| 09/09/2011 | WO2011109355A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | WO2011109345A1 Isotopically enriched arylsulfonamide ccr3 antagonists |
| 09/09/2011 | WO2011109333A1 6 -benzylphenyl- 2 - sulfurterahydropyran-3, 4, 5 -triol derivatives as inhibitors of sodium -glucose cotrans porters 1 and 2 for use in diabetic patients |
| 09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 09/09/2011 | WO2011109267A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | WO2011109261A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | WO2011109254A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | WO2011109232A1 Compositions and methods for treating viral diseases |
| 09/09/2011 | WO2011109130A1 Threads of hyaluronic acid and methods of use thereof |
| 09/09/2011 | WO2011109129A1 Threads of cross-linked hyaluronic acid and methods of use thereof |
| 09/09/2011 | WO2011109059A1 Compounds for treatment of cancer |
| 09/09/2011 | WO2011109012A1 Use of 2'-deoxy-4'-thiocytidine and its analogues as dna hypomethylating anticancer agents |